Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Abstracts Topic Center

Advertisement

Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant...
08/23/2024
Journal of Clinical Pathways
Abstracts
Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Beyond the Diagnosis: Exploring the Multifaceted Distress Profile of Patients With Cancer
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify...
08/23/2024
Journal of Clinical Pathways
Abstracts
A Pilot Program of Automated Patient Identification for Survivorship Resources Using Clinical Oncology Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records...
08/23/2024
Journal of Clinical Pathways
Abstracts
Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment...
08/23/2024
Journal of Clinical Pathways
Abstracts
Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensification in Prostate Cancer
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology
08/23/2024
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are...
08/23/2024
Journal of Clinical Pathways
Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant...
08/23/2024
Journal of Clinical Pathways
Abstracts
Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Beyond the Diagnosis: Exploring the Multifaceted Distress Profile of Patients With Cancer
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify...
08/23/2024
Journal of Clinical Pathways
Abstracts
A Pilot Program of Automated Patient Identification for Survivorship Resources Using Clinical Oncology Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records...
08/23/2024
Journal of Clinical Pathways
Abstracts
Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment...
08/23/2024
Journal of Clinical Pathways
Abstracts
Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensification in Prostate Cancer
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology
08/23/2024
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are...
08/23/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Videos
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
11/12/2024
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD,...
11/12/2024
Journal of Clinical Pathways
BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
Videos
Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships
11/04/2024
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Videos
Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care
11/01/2024
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice...
11/01/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Maximizing the Potential of Precision Medicine
10/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health...
10/07/2024
Cancer Care Business Exchange

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement